Free NLS Pharmaceutics Ltd. (NLSP) Technical Analysis Signals
NLS Pharmaceutics Ltd. (NLSP) signal with technical analysis on 29 Oct
DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1MIDPOINT Slope 2MIDPOINT Slope 3MIDPOINT Slope 4T3 Slope 1T3 Slope 2TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdDEMA with ATR 1DEMA with ATR 2DEMA with ATR 3ADXR with DI+/DI-Donchian ChannelCMO Divergence 1
Belt-hold Closing Marubozu Long Line Candle Marubozu
Overall Strategy:
Buy Signals: 0
Sell Signals: 26
Neutral Signals: 73
Result: This strategy leads to a Sell position.
Disclaimer! Please exercise caution and thorough consideration before making any financial decisions. It's important to note that our signals are based solely on daily price changes and do not take into account external factors such as news, market sentiment, or company developments. We strongly recommend considering all relevant factors and conducting your own research.
Useful Tips: To make the most informed decisions about your NLS Pharmaceutics Ltd. (NLSP) investments, we highly recommend visiting the "Magic Prediction" AI models signals website. They provide free signals, and if one aligns with ours, it is likely to be a reliable indicator, as we have observed over time.
Result: Looking at the technical analysis for NLS Pharmaceutics Ltd. (NLSP) on , there is a tendency towards a sell signal based on historical data and analysis. However, it’s crucial to remember that these signals are not guarantees. Make sure to carefully consider overall market conditions and align your decisions with your specific investment goals.
Based on the above signals and forecasts, we recommend the following strategies:
NLS Pharmaceutics Ltd. (NLSP) trading strategy for those in buy positions (long positions): If you are currently in a buy (long) position, it is advisable to identify the optimal time to exit your position based on a combination of technical signals. Those with a high risk tolerance may choose to wait and observe market movements over the next few days.
NLS Pharmaceutics Ltd. (NLSP) trading strategy for those in sell positions (short positions): If you are in a sell (short) position, holding your position may be the right strategy, as indicated by the consensus of our technical analysis. However, be cautious and monitor market developments closely.
For new positions: If you are not currently invested or considering switching to a sell (short) position, it’s recommended to assess the potential downside of INF% based on the lowest expected price range. Ensure that this aligns with your risk tolerance and objectives by conducting thorough research before entering a short position.
In all trading scenarios, a well-defined stop-loss strategy is critical to managing potential downside risks effectively.
Useful Tip: For long-term forecasting, we recommend using the "Predict-price" website, which offers both short-term and long-term predictions at no cost. This resource can support informed decision-making regarding your **NLS Pharmaceutics Ltd. (NLSP)** investments.
NLS Pharmaceutics Ltd. (NLSP) Price Analysis and Support Levels:
In our current NLS Pharmaceutics Ltd. (NLSP) position, we find ourselves in a short position, anticipating a potential downward trend. Understanding the key support levels is essential, as these serve as critical reference points for traders and investors to make informed decisions.First Support Level: 0
We are closely monitoring the price at 0, the first support level. If the downward trend continues, breaching this level would signal strong selling pressure, suggesting the possibility of further price depreciation.
These support levels should be carefully considered within the context of broader market trends and indicators. By staying alert and consistently analyzing the market, you can make well-informed decisions while trading NLS Pharmaceutics Ltd. (NLSP). Keeping these support levels in mind will help you adapt to the dynamic nature of the market and make smarter trading choices.
NLS Pharmaceutics Ltd. (NLSP) technical analysis chart
NLS Pharmaceutics Ltd. (NLSP) support and resistance levels
| Name | Level1 | Level2 | Level3 | Level4 | Level5 |
|---|---|---|---|---|---|
| Resistance | 17.1 | 18.1 | 19 | -- | -- |
| Support | -- | -- | -- | -- | -- |
NLS Pharmaceutics Ltd. (NLSP) signals list for 29 Oct
| Overall Signals |
|---|
NLS Pharmaceutics Ltd. (NLSP) candlestick patterns on 29 Oct
NLS Pharmaceutics Ltd. (NLSP) technical analysis over the past days
| # | Date | Overal Signals | ALL Signals |
|---|---|---|---|
| 1 | 29 Oct | S | DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1MIDPOINT Slope 2MIDPOINT Slope 3MIDPOINT Slope 4T3 Slope 1T3 Slope 2TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2CMO Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdDEMA with ATR 2DEMA with ATR 3ADXR with DI+/DI-Donchian ChannelDaily Pivot Point 1CMO Divergence 1 |
| 2 | 28 Oct | S | DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1MIDPOINT Slope 4T3 Slope 1TEMA Price 3TRIMA Slope 1TRIMA Slope 2PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdDEMA with ATR 3Volume SpikeADXR with DI+/DI-Donchian ChannelDaily Pivot Point 1CMO Divergence 1 |
| 3 | 27 Oct | S | DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1T3 Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdBBANDS Breakout 2ADXR with DI+/DI-CMO Divergence 1 |
| 4 | 24 Oct | S | DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1MIDPOINT Slope 2MIDPOINT Slope 3MIDPOINT Slope 4T3 Slope 1TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3AROONOSC 1AROONOSC 3CMO Crossover 1PLUS_DI Threshold 1PLUS_DI Threshold 2WILLR Exit OversoldWILLR Exit OverboughtBOP Smoothed ThresholdMACD Crossover 1STOCH Normal Zone CrossDEMA with ATR 1DEMA with ATR 2DEMA with ATR 3Volume SpikeADXR with DI+/DI-Keltner Channel 1Donchian ChannelCMO Divergence 1 |
| 5 | 23 Oct | S | DEMA 1DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4WMA Crossover 1TEMA Price 1TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2Stochastic RSI SignalADXR with DI+/DI-CMO Divergence 1 |
| 6 | 22 Oct | S | DEMA 1DEMA 2KAMA 2KAMA 3KAMA 4WMA Crossover 1TEMA Price 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2ADXR with DI+/DI-CMO Divergence 1 |
| 7 | 21 Oct | N | DEMA 1KAMA 1KAMA 2KAMA 3KAMA 4TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3CCI Crossover 1CCI Crossover 2CCI Crossover 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdMACD Crossover 1Money Flow IndexHammer / Hanging ManADXR with DI+/DI- |
| 8 | 20 Oct | N | DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2RSI Exit OversoldBOP Smoothed ThresholdStochastic RSI SignalADXR with DI+/DI-CMO Divergence 2 |
| 9 | 17 Oct | S | DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4WMA Crossover 5MIDPOINT Slope 2MIDPOINT Slope 3MIDPOINT Slope 4TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2WILLR Exit OverboughtBOP Smoothed ThresholdDaily Pivot Point 1CMO Divergence 1CMO Divergence 2 |
| 10 | 16 Oct | S | DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 4TEMA Price 3TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3CCI Crossover 1CCI Crossover 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdEngulfing PatternCMO Divergence 1 |
| 11 | 15 Oct | S | DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4T3 Slope 2TRIMA Slope 1TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdSTOCH Normal Zone CrossStochastic RSI SignalCMO Divergence 2 |
| 12 | 14 Oct | S | DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 3T3 Slope 2TEMA Price 3TRIMA Slope 2TRIMA Slope 3PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed Threshold |
| 13 | 13 Oct | S | KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 2MIDPOINT Slope 3MIDPOINT Slope 4T3 Slope 2TEMA Price 3TRIMA Slope 2AROONOSC 1AROONOSC 2AROONOSC 3AROONOSC 4PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdIchimoku 1Daily Pivot Point 1CMO Divergence 1 |
| 14 | 10 Oct | S | KAMA 2KAMA 3KAMA 4MIDPOINT Slope 2T3 Slope 2TRIMA Slope 1CCI Crossover 1PLUS_DI Threshold 1PLUS_DI Threshold 2BOP Smoothed ThresholdStochastic RSI SignalPercentage Price Oscillator |
| 15 | 09 Oct | S | KAMA 2EMA Crossover 3MIDPOINT Slope 2MIDPOINT Slope 3T3 Slope 1TEMA Price 3TRIMA Slope 2AROONOSC 1AROONOSC 2AROONOSC 3MOM Crossover 2PLUS_DI Threshold 1PLUS_DI Threshold 2ROC Threshold 2ROCR Threshold 3TRIX Crossover 2BOP Smoothed ThresholdDaily Pivot Point 1CMO Divergence 1CMO Divergence 2 |
| 16 | 02 Sep | S | KAMA 2WMA Crossover 3MIDPOINT Slope 2MIDPOINT Slope 4T3 Slope 1TEMA Price 3TRIMA Slope 1TRIMA Slope 2PLUS_DI Threshold 1WILLR Exit OversoldWILLR Exit OverboughtBOP Smoothed ThresholdOBV CrossoverDaily Pivot Point 1CMO Divergence 1 |
| 17 | 29 Aug | S | KAMA 2MIDPOINT Slope 1MIDPOINT Slope 2T3 Slope 1TEMA Price 3TRIMA Slope 1TRIMA Slope 2PLUS_DI Threshold 1TRIX Crossover 1 |
| 18 | 28 Aug | S | DEMA 2KAMA 2MIDPOINT Slope 1T3 Slope 1TEMA Price 2TEMA Price 3TRIMA Slope 1MOM Crossover 1PLUS_DI Threshold 1ROC Threshold 1ROCR Threshold 2BOP Smoothed ThresholdMACD Crossover 2Chaikin ADOSC Zero Cross |
| 19 | 27 Aug | S | DEMA 1DEMA 2DEMA 3EMA Price Cross 3KAMA 1KAMA 2EMA Crossover 2WMA Crossover 2MIDPOINT Slope 1MIDPOINT Slope 2TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 3SAR CrossoverWILLR Exit OversoldBOP Smoothed ThresholdBBANDS Breakout 1Chaikin AD CrossoverDEMA with ATR 1DEMA with ATR 2DEMA with ATR 3Volume SpikeIchimoku 2Ichimoku 3Rolling VWAPVortex IndicatorElder's Force IndexCMO Divergence 1 |
| 20 | 26 Aug | S | DEMA 1DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 4T3 Slope 1TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1TRIMA Slope 2CCI Crossover 3PLUS_DI Threshold 1PLUS_DI Threshold 2RSI Exit OversoldBOP Smoothed ThresholdStochastic RSI Signal |
| 21 | 30 Jul | N | DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1MIDPOINT Slope 4T3 Slope 1TEMA Price 3TRIMA Slope 1TRIMA Slope 2PLUS_DI Threshold 1PLUS_DI Threshold 2WILLR Exit OversoldWILLR Exit OverboughtBOP Smoothed ThresholdEngulfing PatternCMO Divergence 1 |
| 22 | 29 Jul | S | DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4T3 Slope 1TRIMA Slope 1PLUS_DI Threshold 1PLUS_DI Threshold 2RSI Exit OversoldBOP Smoothed ThresholdStochastic RSI Signal |
| 23 | 28 Jul | S | DEMA 1DEMA 2DEMA 3KAMA 1KAMA 2KAMA 3KAMA 4MIDPOINT Slope 1MIDPOINT Slope 2MIDPOINT Slope 4T3 Slope 1TEMA Price 1TEMA Price 2TEMA Price 3TRIMA Slope 1AROONOSC 3AROONOSC 4PLUS_DI Threshold 1WILLR Exit OversoldWILLR Exit OverboughtBOP Smoothed ThresholdMACD Crossover 1Donchian ChannelCMO Divergence 1 |
| 24 | 25 Jul | S | EMA Price Cross 4KAMA 2KAMA 3KAMA 4MIDPOINT Slope 2TEMA Price 3TRIMA Slope 1AROONOSC 1PLUS_DI Threshold 1BOP Smoothed ThresholdSTOCH Normal Zone CrossElder's Force Index |
| 25 | 24 Jul | S |
Users forecasts for NLS Pharmaceutics Ltd. (NLSP)
What is your prediction?
In this section, you can easily predict without user registration. See also other users predictions.